155
Views
8
CrossRef citations to date
0
Altmetric
Editorial

DNase1: a new personalized therapy for cancer?

Pages 983-986 | Published online: 10 Jan 2014
 

Acknowledgements

Ms Evangelia Kirou is thanked for excellent work in reviewing the manuscript and for enlightening scientific discussions. Dr Nissim Ohana is thanked for helpful suggestions.

Financial & competing interests disclosure

The author has a patent pending through Wayne State University for use of deoxyribonuclease 1 in cancer treatment. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.